InvestSMART

Artrya Limited (ASX: AYA) - Announcements

Current share price for AYA : $4.810 0.12 (2.56%)+

ASX company news and announcements for Artrya Limited (AYA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Artrya Limited (AYA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Artrya Limited (AYA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Artrya Limited (AYA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$784 Response to ASX Query 2 Nov 2023 7:07PM $0.220 $4.810 risen by 2,086.36%
$784 2023 Corporate Governance Statement and Appendix 4G 27 Oct 2023 5:18PM $0.200 $4.810 risen by 2,305%
$784 2023 Annual Report 27 Oct 2023 5:17PM $0.200 $4.810 risen by 2,305%
$784 Notice of Annual General Meeting/Proxy Form 27 Oct 2023 5:11PM $0.200 $4.810 risen by 2,305%
$784 Quarterly Activity Report and Appendix 4C 19 Oct 2023 10:08AM $0.230 $4.810 risen by 1,991.30%
$784 Change of Registry Address Notification 13 Sep 2023 5:32PM $0.260 $4.810 risen by 1,750%
$784 Application for quotation of securities - AYA 4 Sep 2023 5:57PM $0.315 $4.810 risen by 1,426.98%
$784 Issue of Shares on Exercise of Options and Cleansing Notice 4 Sep 2023 5:50PM $0.315 $4.810 risen by 1,426.98%
$784 Appendix 4E and Annual Financial Report - 30 June 2023 31 Aug 2023 3:04PM $0.330 $4.810 risen by 1,357.58%
$784 Clarification Announcement 16 Aug 2023 12:52PM $0.335 $4.810 risen by 1,335.82%
$784 Rescheduled Investor Call 25 Jul 2023 7:11PM $0.230 $4.810 risen by 1,991.30%
$784 Quarterly Activity Report and Appendix 4C-June 2023 24 Jul 2023 9:07AM $0.230 $4.810 risen by 1,991.30%
$784 Notification of cessation of securities - AYA 19 Jun 2023 6:00PM $0.210 $4.810 risen by 2,190.48%
$784 Application for quotation of securities - AYA 14 Jun 2023 6:25PM $0.220 $4.810 risen by 2,086.36%
$784 Secondary Trading Notice 14 Jun 2023 6:25PM $0.220 $4.810 risen by 2,086.36%
$784 Company Presentation - MST Digital Health Forum 13 Jun 2023 9:15AM $0.205 $4.810 risen by 2,246.34%
$784 AYA Conducts Successful Q-Submission Meeting with FDA 9 Jun 2023 1:25PM $0.205 $4.810 risen by 2,246.34%
$784 Change of Director's Interest Notice - K Hill 12 May 2023 5:42PM $0.250 $4.810 risen by 1,824%
$784 Artrya Lodges Key Submission in FDA Process 3 May 2023 9:38AM $0.250 $4.810 risen by 1,824%
$784 Becoming a substantial holder 27 Apr 2023 5:19PM $0.270 $4.810 risen by 1,681.48%
$784 Quarterly Activity Report and Appendix 4C-March 2023 19 Apr 2023 8:53AM $0.225 $4.810 risen by 2,037.78%
$784 Investor Presentation 4 Apr 2023 9:09AM $0.300 $4.810 risen by 1,503.33%
$784 Change of Director's Interest Notice - B Ridgeway 31 Mar 2023 8:05PM $0.333 $4.810 risen by 1,346.62%
$784 Notification regarding unquoted securities - AYA 28 Mar 2023 7:14PM $0.265 $4.810 risen by 1,715.09%
$784 Final Director's Interest Notice - J Barrington 27 Mar 2023 1:25PM $0.240 $4.810 risen by 1,904.17%

226 - 250 of 504 results

Page 10 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.